(Total Views: 147)
Posted On: 06/01/2022 10:30:50 AM
Post# of 47159

$SAGE News Article - Sage Therapeutics and Biogen Announce that the Phase 3 SKYLARK Study of Zuranolone in Postpartum Depression Met its Primary and All Key Secondary Endpoints https://marketwirenews.com/news-releases/sage...79502.html


My Twitter: WhyteStocks